Pictet Asset Management Holding Sa Xenon Pharmaceuticals Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,477,617 shares of XENE stock, worth $42.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,477,617
Previous 1,496,511
1.26%
Holding current value
$42.6 Million
Previous $58.7 Million
15.49%
% of portfolio
0.06%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$166 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$132 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$109 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$95.9 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$89.1 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.8B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...